Drug Shortage Report for TEVA-OXYCOCET
| Report ID | 253150 |
| Drug Identification Number | 00608165 |
| Brand name | TEVA-OXYCOCET |
| Common or Proper name | TEVA-OXYCOCET TABLETS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ACETAMINOPHEN OXYCODONE HYDROCHLORIDE |
| Strength(s) | 325MG 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N02AJ |
| ATC description | OPIOIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-03-19 |
| Estimated end date | 2025-12-12 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-12-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v47 | 2025-12-05 | French | Compare |
| v46 | 2025-12-05 | English | Compare |
| v45 | 2025-12-04 | French | Compare |
| v44 | 2025-12-04 | English | Compare |
| v43 | 2025-11-27 | French | Compare |
| v42 | 2025-11-27 | English | Compare |
| v41 | 2025-11-13 | French | Compare |
| v40 | 2025-11-13 | English | Compare |
| v39 | 2025-11-06 | French | Compare |
| v38 | 2025-11-06 | English | Compare |
| v37 | 2025-11-05 | French | Compare |
| v36 | 2025-11-05 | English | Compare |
| v35 | 2025-11-03 | French | Compare |
| v34 | 2025-11-03 | English | Compare |
| v33 | 2025-10-16 | French | Compare |
| v32 | 2025-10-16 | English | Compare |
| v31 | 2025-10-10 | French | Compare |
| v30 | 2025-10-10 | English | Compare |
| v29 | 2025-10-02 | French | Compare |
| v28 | 2025-10-02 | English | Compare |